GT Biopharma GTBP
NASDAQ GTBP
$5.41 -1.90 (-25.99%)
At close: Oct 21, 2026 · 4:00 PM EDT

GT Biopharma (GTBP) Current Debt (2011 - 2017)

Updated

Analysis

GT Biopharma (GTBP) Current Debt (2011 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Debt (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 3.51 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -5.75 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 208.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 64.00 Mn
10 GT Biopharma 6.53 Mn -16.96 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2017 195,000.00
Mar 31, 2017 866,000.00
Jun 30, 2016 1.39 Mn
Mar 31, 2016 150,000.00
Sep 30, 2015 550,000.00
Mar 31, 2015 2.35 Mn
Sep 30, 2014 1.24 Mn
Jun 30, 2014 39,000.00
Mar 31, 2014 50,000.00
Mar 31, 2013 35,000.00
Sep 30, 2012 207,000.00
Jun 30, 2012 188,000.00
Mar 31, 2012 220,000.00
Mar 31, 2011 94,000.00
API Access

GT Biopharma Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-debt&ticker=GTBP&period=max&api_key=YOUR_API_KEY